About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
SABCS 2022 Expert Panel Discussion: Practice-Changing Updates
By
SABCS 2022 Conference Coverage
FEATURING
Joyce O'Shaughnessy
,
Sara Tolaney
,
Sara A. Hurvitz
,
Hope Rugo
December 13, 2022
2 Comments
Login to view comments.
Click here to Login
Featured Video
17:04
Novartis Oncology
Discussion on Overall Survival Data Across 3 Phase III Trials in HR+…
Feat.
G. Hortobagyi
Featured Video
18:15
Novartis Oncology
CDK4/6 Inhibitor in Postmenopausal Patients With HR+/HER2- mBC: Anal…
Feat.
G. Hortobagyi
Related Content
AUTOPLAY
ON
19:05
International Congress on Cancer Metastasis
Could We Cure Metastatic Breast Cancer?
Feat.
L. Pusztai
01:06
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Preliminary Analysis of an Expanded Acce…
Feat.
C. Dang
09:57
ASCO 2022 Conference Coverage
ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…
Feat.
C. Dang
48:31
Michael Wendt
Pharmacological Targeting of Metastatic Breast Cancer: BC Cells Effi…
13:07
Holy Cross 9th Annual Winter Oncology Symposium
Panel Discussion on Breast Cancer: Promising Drugs and Future Treatm…
Feat.
E. Segota,
R. L. Mahtani,
J. Burgers,
M. Abu-Khalaf,
B. Moy
28:34
Breast Health Global Initiative
Clinical Pathways for Early Diagnosis of Breast Cancer
10:00
12th ESO-EONS Masterclass in Oncology Nursing
Breast Cancer Global Epidemiology (Nurses)
Feat.
O. Pagani
17:17
2020 Best of Breast
Treatment of 57 y/o Post-Menopausal Woman With HER2+ Breast Cancer: …
Feat.
R. L. Mahtani
03:40
19th Conference of the International Society of Geriatric Oncology
Serious Adverse Events Among Older Patients in the ALTTO Trial Compa…
Feat.
L. Dal Lago
19:41
8th International Congress on Cancer Metastasis
The Genomic Evolution of Breast Cancer Metastasis: Metastases Mostly…
Feat.
L. Yates
10:04
12th ESO-EONS Masterclass in Oncology Nursing
Early Breast Cancer Treatment: Decisive Steps & Disease Complexi…
Feat.
O. Pagani
07:58
12th ESO-EONS Masterclass in Oncology Nursing
Triple Negative Disease: Adjuvant Therapy, Hormone Receptor + Diseas…
Feat.
O. Pagani
09:47
19th Conference of the International Society of Geriatric Oncology
Radiation Therapy in HER+ Breast Cancer: Relative Benefits Are Const…
Feat.
R. Simcock
03:02
19th Conference of the International Society of Geriatric Oncology
79 y/o Female w/ HER+ Breast Cancer: Questions on (Neo)Adjuvant Chem…
Feat.
E. Perez De Celis
11:46
KU 2019 Post San Antonio Breast Cancer Review
52 y/o With HER2+/HR- De-novo Metastatic BC / 52 y/o With T2N0 HR+/H…
Feat.
A. Kurian,
Q. Khan,
P. Sharma,
V. Kaklamani,
T. Mamounas,
W. Gradishar
12:30
Sandra Swain
A Brief History of HER2+ Breast Cancer
06:09
Total Health
2020 ASCO MINDACT Trial Data on MammaPrint in EBC: Can Genomic Profi…
Feat.
R. Gupta
17:02
Ashley Mathews
The Breast Tumor Microenvironment: Triple-Negative and HER2+ Carcino…
02:46
19th Conference of the International Society of Geriatric Oncology
The Prevalence of Luminal B Subtype Is Higher in Older Postmenopausa…
Feat.
M. Mills
14:34
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure
Enhancing the Impact of IO in Metastatic / Locally Advanced TNBC: At…
Feat.
H. Rugo
